(2005). Cellular and molecular mechanisms of the epithelial repair in IBD. Dig Dis Sci
(2004). Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther
(2005). Dignass AU: Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism.
(1992). Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology
(2003). Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.
(2005). Immunity, inflammation, and allergy in the gut. Science
(1998). Inflammatory Bowel Disease: Etiology and Pathogenesis. Gastroenterology
(2007). Itzikowitz S: Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a review and update. Inflammatory Bowel Disease
(2006). JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
(2005). Leufkens HGM: 5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut
(1998). MD: Impediments to Wound Healing.
(2003). Mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease. Aliment Pharmacol Ther
(1997). Paraskeva C: Butyrate-but not TGFβ1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatise. Cell Death Diff
(2002). Paraskeva C: Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut
(2007). Paraskeva C: Prostaglandin F2(alpha) stimulates motility and invasion in colorectal tumour cells.
(1993). Paraskeva C: Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53 independent pathway: implications for the possible role of dietary fibre in the prevention of large bowel cancer.
(2000). PD: C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene
(2000). Rationale for the luminal provision of butyrate in intestinal diseases.
(1990). RG: Short chain fatty acids; production, absorption, metabolism and intestinal effects. In Dietary Fiber: chemistry, physiology and health effects. Edited by: Kretchevsky
(2003). Schmiegel W: Mesalazine causes a mitotic arrest and induces caspasedependent apoptosis in colon carcinoma cells. Carcinogenesis
(1997). Short chain fatty acids promote the migration of colonic epithelial cells in vitro. Gastroenterology
(2009). The actin bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro.
(2003). The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther
(2004). The long-term management of ulcerative colitis. Aliment Pharmacol Ther
Trempe G: New human tumour cell lines. In Human tumour cells in vitro. Edited by: Fogh J.